EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rosenberg S, 1987, Surgical Treatment of Metastatic Cancer. Lippincott: Philadelphia.
Fidler IJ and Balch CM, 1987, The biology of cancer metastasis and implications for therapy. Curr Prob Surg, 24, 129–209.
Sugarbaker EV, 1979, Cancer metastasis: a product of tumor-host interactions. Curr Prob Cancer,3, 1–59.
Nabi IR, Watanabe H and Raz A, 1992, Autocrine motility factor and its receptor: role in cell locomotion and metastasis. Cancer Metastasis Rev, 11, 5–20.
Talmadge JE and Fidler IJ, 1989, Phenotypic heterogeneity and metastasis. In: Sirica AE, ed. The Pathobiology of Neoplasia. New York:Plenum Press, pp. 547–72.
Lu C and Kerbel RS, 1994, Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma. Curr Opin Oncol, 6, 212–20.
Yeatman TJ and Nicolson GL, 1993, Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis. Seminars Surg Oncol, 9, 256–63.
Rinker-Schaeffer CW, Partin AW, Isaacs WB, et al. 1994, Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate, 25, 249–265.
Monsky WL and Chen WT, 1993, Proteases of cell adhesion proteins in cancer. Seminars Cancer Biol, 4, 251–8.
Aznavoorian S, Murphy AN, Stetler-Stevenson WG, et al. 1993, Molecular aspects of tumor cell invasion and metastasis. Cancer, 71, 1368–83.
Jones JG, Segall J and Condeelis J, 1991, Molecular analysis of amoeboid chemotaxis: parallel observations in amoeboid phagocytes and metastatic tumor cells. Experientia Suppl, 59, 1–16.
Condeelis J, 1993, Life at the leading edge: the formation of cell protrusion. Ann Rev Cell Biol, 9, 411–44.
Devreotes PN and Zigmond SH, 1988, Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium. Ann Rev Cell Biol, 4, 649–86.
Silletti S and Raz A, 1993, Autocrine motility factor is a growth factor. Biochem Biophys Res Commun, 194, 446–57.
Stracke M, Liotta LA and Schiffmann E, 1993, The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility. Symp Soc Exp Biol, 47, 197–214.
Hoelting T, Siperstein AE, Clark OH, et al. 1994, Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo. J Clin Endocr Metab, 79, 401–8.
Pedersen PH, Ness GO, Engebraaten O, et al. 1994, Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion. Int J Cancer, 56, 255–61.
Wang X, Kamiyama K, Iguchi I, et al. 1994, Enhancement of fibronectin-induced migration of corneal epithelial cells by cytokines. Invest Ophthalmol Vis Sci, 35, 4001–7.
Royce LS and Baum BJ, 1991, Physiologic levels of salivary epidermal growth factor stimulate migration of an oral epithelial cell line. Biochim Biophys Acta, 1092, 401–3.
Grotendorst GR, Soma Y, Takehara K, et al. 1989, EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J Cell Physiol, 139, 617–23.
Blay J and Brown KD, 1985, Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J Cell Physiol, 124, 107–12.
Kundra V, Escobedo JA, Kazlauskas A, et al. 1994, Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature, 367, 474–6.
Yenush L, Kundra V, White MF, et al. 1994, Functional domains of the insulin receptor responsible for chemotactic signaling. J Biol Chem, 269, 100–4.
Li Y, Bhargava MM, Joseph A, et al. 1994, Effect of hepatocyte growth factor/scatter factor and other growth factors on motility and morphology of non-tumorigenic and tumor cells. In Vitro Cell Devel Biol An, 30A, 105–10.
Gherardi E, Sharpe M, Lane K, et al. 1993, Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells. Symp Soc Exp Biol, 47, 163–81.
Khazaie K, Schirrmacher V and Lichtner RB, 1993, EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev, 12, 255–74.
Weidner N and Gasparini G, 1994, Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients. Breast Canc Res Treat, 29, 97–107.
Fox SB, Smith K, Hollyer J, et al. 1994, The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Canc Res Treat, 29, 41–9.
Veale D, Kerr N, Gibson GJ, et al. 1993, The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br J Cancer, 68, 162–5.
Mayer A, Takimoto M, Fritz E, et al. 1993, The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer, 71, 2454–60.
Itakura Y, Sasano H, Shiga C, et al. 1994, Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer, 74, 795–804.
Peppelenbosch MP, Tertoolen LG, Hage WJ, et al. 1993, Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell, 74, 565–75.
Kuppuswamy D and Pike LJ, 1991, Desensitization of the EGF receptor alters its ability to undergo EGF-induced dimerization. Cell Signalling, 3, 107–17.
Osherov N and Levitzki A, 1994, Epidermal-growthfactor-dependent activation of the src-family kinases. Eur J Biochem, 225, 1047–53.
Dadabay CY, Patton E, Cooper JA, et al. 1991, Lack of correlation between changes in polyphosphoinositide levels and actin/gelsolin complexes in A431 cells treated with epidermal growth factor. J Cell Biol, 112, 1151–6.
Price JE, Sauder DN and Fidler IJ, 1988, Tumorigenicity and metastatic behavior in nude mice of two human squamous cell carcinoma lines that differ in production of the cytokine ETAF/IL-1. J Invest Dermatol, 91, 258–62.
Neri A, Welch D, Kawaguchi T, et al. 1982, Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst, 68, 507–17.
Welch DR, Neri A and Nicolson GL, 1983, Comparison of ‘spontaneous’ and ‘experimental’ metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis, 3, 65–80.
Welch DR, Krizman DB and Nicolson GL, 1984, Multiple phenotypic divergence of mammary adenocarcinoma cell lines. I. In vitro and in vivo properties. Clin Exp Metastasis, 2, 333–55.
Kaufmann AM, Khazaie K, Wiedemuth M, et al. 1994, Expression of epidermal growth factor receptor correlates with metastatic potential of 13762NF rat mammary adenocarcinoma cells. Int J Oncol, 4, 1149–55.
Lichtner RB, Wiedemuth M, Kittmann A, et al. 1992, Ligand-induced activation of epidermal growth factor receptor in intact rat mammary adenocarcinoma cells without detectable receptor phosphorylation. J Biol Chem, 267, 11872–80.
Soil DR, 1988, ‘DMS,’ a computer-assisted system for quantitating motility, the dynamics of cytoplasmic flow, and pseudopod formation: its application to Dictyostelium chemotaxis. Cell Motil Cytoskeleton, 10, 91–106.
Condeelis J and Hall AL, 1991, Measurement of actin polymerization and cross-linking in agonist-stimulated cells. Meth Enzymol, 196, 486–96.
Sampath P and Pollard TD, 1991, Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochemistry, 19, 1973–80.
Lichtner RB, Wiedemuth M, Noeske-Jungblut C, et al. 1993, Rapid effects of EGF on cytoskeletal structures and adhesive properties of highly metastatic rat mammary adenocarcinoma cells. Clin Exp Metastasis, 11, 113–25.
Jordan MA, Thrower D and Wilson L, 1992, Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J Cell Sci, 102, 401–16.
Chinkers M, McKanna JA and Cohen S, 1981, Rapid rounding of human epidermoid carcinoma cells A-431 induced by epidermal growth factor. J Cell Biol, 88, 422–9.
Chinkers M, McKanna JA and Cohen S, 1979, Rapid induction of morphological changes in human carcinoma cells A-431 by epidermal growth factor. J Cell Biol, 83, 260–5.
Miyata Y, Nishida E and Sakai H, 1988, Growth factor- and phorbol ester-induced changes in cell morphology analyzed by digital image processing. Exp Cell Res, 175, 286–97.
van Larebeke NA, Bracke ME and Mareel MM, 1992, Simple method for quantification of fast plasma membrane movements. Cytometry, 13, 1–8.
Welsh JB, Gill GN, Rosenfeld MG, et al. 1991, A negative feedback loop attenuates EGF-induced morphological changes. J Cell Biol, 114, 533–43.
Kadowaki T, Koyasu S, Nishida E, et al. 1986, Insulin-like growth factors, insulin, and epidermal growth factor cause rapid cytoskeletal reorganization in KB cells. Clarification of the roles of type I insulin-like growth factor receptors and insulin receptors. J Biol Chem, 261, 16141–7.
Wrann MM and Fox CF, 1979, Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line. J Biol Chem, 254, 8083–6.
Lichtner RB and Schirrmacher V, 1990, Cellular distribution and biological activity of epidermal growth factor receptors in A431 cells are influenced by cell-cell contact. J Cell Physiol, 144, 303–12.
Koyasu S, Kadowaki T, Nishida E, et al. 1988, Alteration in growth, morphology, and cytoskeletal structures of KB cells induced by epidermal growth factor and transforming growth factor-beta. Exp Cell Res, 176, 107–16.
Gill GN and Lazar CS, 1981, Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature, 293, 305–7.
Kawamoto T, Sato JD, Le A, et al. 1983, Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA, 80, 1337–41.
Richer M, Castillo MA, Rieber MS, et al. 1988, Decrease in tumor-cell attachment and in a 140-kDa fibronectin receptor correlate with greater expression of multiple 34-kDa surface proteins and cytoplasmic 54-kDa components. Int J Cancer, 41, 96–100.
Nakajima M, Welch DR, Wynn DM, et al. 1993, Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res, 53, 5802–7.
Schechter B, Arnon R, Wilchek M, et al. 1991, Indirect immunotargeting of cis-Pt to human epidermoid carcinoma KB using the avidin-biotin system. Int J Cancer, 48, 167–72.
Aboud-Pirak E, Hurwitz E, Pirak ME, et al. 1988, Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J Natl Cancer Inst, 80, 1605–11.
Harvath L, Falk W and Leonard EJ, 1980, Rapid quantitation of neutrophil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly. J Immunol Meth, 37, 39–45.
Rijken PJ, Hage WJ, van Bergen en Henegouwen PM, et al. 1991, Epidermal growth factor induces rapid reorganization of the actin microfilament system in human A431 cells. J Cell Sci, 100, 491–9.
Schlessinger J and Geiger B, 1981, Epidermal growth factor induces redistribution of actin and alpha-actinin in human epidermal carcinoma cells. Exp Cell Res, 134, 273–9.
Egelhoff TT and Spudich JA, 1991, Molecular genetics of cell migration: Dictyostelium as a model system. Trends Genetics, 7, 161–6.
Hall AL, Warren V, Dharmawardhane S, et al. 1989, Identification of actin nucleation activity and polymerization inhibitor in ameboid cells: their regulation by chemotactic stimulation. J Cell Biol, 109, 2207–13.
Theriot JA and Mitchison TJ, 1992, Comparison of actin and cell surface dynamics in motile fibroblasts. J Cell Biol, 119, 367–77.
Bates SE, Valverius EM, Ennis BW, et al. 1990, Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinology, 126, 596–607.
Coleman S, Silberstein GB and Daniel CW, 1988, Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Develop Biol, 127, 304–15.
Snedeker SM, Brown CF and DiAugustine RP, 1991, Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA, 88, 276–80.
Atnip KD, Carter LM, Nicolson GL, et al. 1987, Chemotactic response of rat mammary adenocarcinoma cell clones to tumor-derived cytokines. Biochem Biophys Res Commun, 146, 996–1002.